From: Outcome and prognostic factors of CBF pediatric AML patients with t(8;21) differ from patients with inv(16)
CBF
inv(16)
t(8;21)
P
%
95%CI
CR
95.2
94
95.9
0.441
CIR
Median, years
3.9
3.6
4.1
10 years
29.4
24.9–33.9
35.2
27.9–42.6
25.4
19.9–31.2
0.026
OS
4.9
5.2
4.6
84.4
80.5–88.5
89.5
84.7–94.6
80.7
75.1–86.8
0.027